China Universal Asset Management »

AstraZeneca shares owned by China Universal Asset Management

Quarter-by-quarter ownership of AstraZeneca (AZN) shares owned by China Universal Asset Management from 13F filings

Historical chart of China Universal Asset Management investment in AstraZeneca

Tip: Access up to 7 years of quarterly data

All positions including AstraZeneca held by China Universal Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in AstraZeneca by China Universal Asset Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $7.8M 115k 67.75
2023-12-31 $4.4M 66k 67.35
2023-09-30 $1.2M 17k 67.73
2023-06-30 $595k 8.3k 71.57
2023-03-31 $580k 8.4k 69.45
2022-12-31 $421k 6.2k 67.83
2022-09-30 $313k 5.7k 54.82

More positions owned by China Universal Asset Management

Microsoft Corp Common Stock (MSFT)
Nvidia Corp Common Stock (NVDA)
Amazon.com Common Stock (AMZN)
Meta Platforms Inc-class A Common Stock (META)
Vertex Pharmaceuticals Common Stock (VRTX)
Amgen Common Stock (AMGN)
Servicenow Common Stock (NOW)
Gilead Sciences Common Stock (GILD)
Regeneron Pharmaceuticals Common Stock (REGN)
Alphabet Inc-cl A Common Stock (GOOGL)
Adobe Common Stock (ADBE)
Broadcom Common Stock (AVGO)
Visa Inc-class A Shares Common Stock (V)
Apple Common Stock (AAPL)
Uber Technologies Common Stock (UBER)

View all positions for China Universal Asset Management

Top funds holding AstraZeneca

T. Rowe Price Associates
Wellington Management Company
PRIMECAP Management Company
Jennison Associates
Sanders Capital
Goldman Sachs Group
Bank of America Corporation
Franklin Resources
Fisher Investments
Atlantic Trust
Dimensional Fund Advisors
Holocene Advisors
ClearBridge Advisors
Jpmorgan Chase & Co
Wells Fargo & Company

View all funds holding AstraZeneca